Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal microbiota (colonic) refers to the dense, metabolically active community of microorganisms (primarily bacteria, but also archaea, fungi, viruses) inhabiting the colon and influenced by the local environment, including pH, transit time, nutrient availability, and host immune factors. This ecosystem is critical for fermentation of undigested carbohydrates, production of short-chain fatty acids, immune system maturation, protection against pathogens, and maintenance of colonic health. The colonic environment, characterized by a stable, anaerobic, and nutrient-rich setting, shapes microbial composition, diversity, and their metabolism, which in turn have profound effects on host physiology and disease risk. The entity is not a classical molecular target but rather a complex ecological system, and is thus unsuitable as a "target" in the conventional pharmacological sense.
Alteration of microbial community structure and metabolic activity (by antibiotics, prebiotics, probiotics, FMT); Modulation of immune responses via microbial metabolites
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal microbiota (colonic).